Literature DB >> 20031746

Impact of thrombus aspiration on myocardial tissue reperfusion and left ventricular functional recovery and remodeling after primary angioplasty.

Francesco Liistro1, Simone Grotti, Paolo Angioli, Giovanni Falsini, Kenneth Ducci, Silvia Baldassarre, Alessandra Sabini, Rossella Brandini, Eugenia Capati, Leonardo Bolognese.   

Abstract

BACKGROUND: Failure to achieve myocardial reperfusion often occurs during percutaneous coronary intervention (PCI) in patients with myocardial infarction with ST-segment elevation. We hypothesized that manual thrombus aspiration during primary PCI would favorably influence tissue-level myocardial perfusion and left ventricular (LV) functional recovery and remodeling. METHODS AND
RESULTS: We prospectively randomized 111 patients with ST-segment elevation myocardial infarction to either standard or thrombus-aspiration PCI. Primary end point of the study was postprocedural incidence of ST-segment resolution >or=70%. Secondary end points included Thrombolysis in Myocardial Infarction (TIMI) myocardial perfusion grade >or=2, the combination of TIMI myocardial perfusion grade >or=2 and ST-segment resolution >or=70%, post-PCI TIMI grade 3 flow, corrected TIMI frame count, myocardial contrast echocardiography score index, the absence of persistent ST-segment deviation, and time course of wall-motion score index, LV ejection fraction, and LV volume in the 2 groups. The incidence of ST-segment resolution >or=70% was 71% and 39% in the thrombus-aspiration and standard PCI groups, respectively (odds ratio, 3.7; 95% CI, 1.7 to 8.3; P=0.001). TIMI myocardial perfusion grade >or=2 was attained in 93% in the thrombus-aspiration group compared with 71% in the standard PCI group (P=0.006). The percentage of patients with ST-segment resolution >or=70% and TIMI myocardial perfusion grade >or=2 was significantly greater in the thrombus-aspiration group compared with the standard PCI group (69% versus 36%, P=0.0006). Myocardial contrast echocardiography score index was significantly higher in the thrombus-aspiration group compared with the standard PCI group (0.86+/-0.20 versus 0.65+/-0.31; P<0.0001). A significantly greater improvement in LV ejection fraction and in wall-motion score index from baseline to 6-month follow-up was observed in the thrombus-aspiration group compared with the standard PCI group (LV ejection fraction from 48+/-6% to 55+/-6% versus 48.7+/-7% to 49+/-8%, P<0.0001; wall-motion score index from 1.59+/-0.13 to 1.31+/-0.19 versus 1.64+/-0.20 to 1.51+/-0.26, P=0.008). Twelve patients (11%) developed LV remodeling at 6 months, 2 (4%) in the thrombus-aspiration group and 10 (18%) in the standard PCI group (P=0.02).
CONCLUSIONS: Manual thrombus aspiration in the setting of primary PCI improves myocardial tissue-level perfusion as well as LV functional recovery and remodeling.

Entities:  

Mesh:

Year:  2009        PMID: 20031746     DOI: 10.1161/CIRCINTERVENTIONS.109.852665

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  21 in total

Review 1.  Thrombectomy during primary angioplasty: methods, devices, and clinical trial data.

Authors:  Giuseppe De Luca; Monica Verdoia; Ettore Cassetti
Journal:  Curr Cardiol Rep       Date:  2010-09       Impact factor: 2.931

2.  Manual vs mechanical thrombectomy during PCI for STEMI: a comprehensive direct and adjusted indirect meta-analysis of randomized trials.

Authors:  Eliano Pio Navarese; Giuseppe Tarantini; Giuseppe Musumeci; Massimo Napodano; Roberta Rossini; Mariusz Kowalewski; Anna Szczesniak; Michalina Kołodziejczak; Jacek Kubica
Journal:  Am J Cardiovasc Dis       Date:  2013-08-16

Review 3.  Long-term outcomes with aspiration thrombectomy for patients undergoing primary percutaneous coronary intervention: A meta-analysis of randomized trials.

Authors:  Akram Y Elgendy; Islam Y Elgendy; Ahmed N Mahmoud; Anthony A Bavry
Journal:  Clin Cardiol       Date:  2017-04-13       Impact factor: 2.882

Review 4.  [Thrombus aspiration in patients with acute myocardial infarction : Scientific evidence and guideline recommendations].

Authors:  T Stiermaier; S de Waha; G Fürnau; I Eitel; H Thiele; S Desch
Journal:  Herz       Date:  2016-03-15       Impact factor: 1.443

5.  Preventive percutaneous coronary intervention and aspiration thrombectomy-updates in the management of ST-elevation myocardial infarction.

Authors:  David S Wald; Jonathan P Bestwick
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

6.  Use of Thrombectomy Devices in Primary Percutaneous Interventions for ST-elevation Myocardial Infarction - An Update.

Authors:  Krishnaraj S Rathod; Stephen M Hamshere; Tawfiq R Choudhury; Daniel A Jones; Anthony Mathur
Journal:  Interv Cardiol       Date:  2014-04

7.  Evidence for a novel racemization process of an asparaginyl residue in mouse lysozyme under physiological conditions.

Authors:  K Ueno; T Ueda; K Sakai; Y Abe; N Hamasaki; M Okamoto; T Imoto
Journal:  Cell Mol Life Sci       Date:  2005-01       Impact factor: 9.261

8.  Does manual thrombus aspiration help optimize stent implantation in ST-segment elevation myocardial infarction?

Authors:  Diego Fernández-Rodríguez; Luis Alvarez-Contreras; Victoria Martín-Yuste; Salvatore Brugaletta; Ignacio Ferreira; Marta De Antonio; Montserrat Cardona; Vicens Martí; Juan García-Picart; Manel Sabaté
Journal:  World J Cardiol       Date:  2014-09-26

Review 9.  Thrombus aspiration in acute myocardial infarction.

Authors:  Karim D Mahmoud; Felix Zijlstra
Journal:  Nat Rev Cardiol       Date:  2016-03-10       Impact factor: 32.419

Review 10.  Systematic review: comparative effectiveness of adjunctive devices in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention of native vessels.

Authors:  Diana M Sobieraj; C Michael White; Jeffrey Kluger; Vanita Tongbram; Jennifer Colby; Wendy T Chen; Sagar S Makanji; Soyon Lee; Ajibade Ashaye; Craig I Coleman
Journal:  BMC Cardiovasc Disord       Date:  2011-12-20       Impact factor: 2.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.